Literature DB >> 19223490

Expression of hepatitis C virus (HCV) structural proteins in trans facilitates encapsidation and transmission of HCV subgenomic RNA.

Richard Adair1, Arvind H Patel1, Lynsey Corless2, Stephen Griffin2, David J Rowlands2, Christopher J McCormick3.   

Abstract

A characteristic of many positive-strand RNA viruses is that, whilst replication of the viral genome is dependent on the expression of the majority of non-structural proteins in cis, virus particle formation can occur when most or all of the structural proteins are co-expressed in trans. Making use of a recently identified hepatitis C virus (HCV) isolate (JFH1) that can be propagated in tissue culture, this study sought to establish whether this is also the case for hepaciviruses. Stable cell lines containing one of two bicistronic replicons derived from the JFH1 isolate were generated that expressed non-structural proteins NS3-5B or NS2-5B. Release and transmission of these replicons to naïve Huh7 cells could then be demonstrated when baculovirus transduction was used to express the HCV proteins absent from the subgenomic replicons. Transmission could be blocked by a neutralizing antibody targeted at the E2 envelope protein, consistent with this phenomenon occurring via trans-encapsidation of replicon RNA into virus-like particles. Transmission was also dependent on expression of NS2, which was most effective at promoting virus particle formation when expressed in cis on the replicon RNA compared with in trans via baculovirus delivery. Density gradient analysis of the particles revealed the presence of a broad infectious peak between 1.06 and 1.11 g ml(-1), comparable to that seen when propagating full-length virus in tissue culture. In summary, the trans-encapsidation system described offers a complementary and safer approach to study HCV particle formation and transmission in tissue culture.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19223490     DOI: 10.1099/vir.2008.006049-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

Review 1.  Hepatitis C virus: assembly and release of virus particles.

Authors:  Daniel M Jones; John McLauchlan
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  The acidic domain of hepatitis C virus NS4A contributes to RNA replication and virus particle assembly.

Authors:  Tung Phan; Andrew Kohlway; Peniel Dimberu; Anna Marie Pyle; Brett D Lindenbach
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

3.  Production of infectious hepatitis C virus by using RNA polymerase I-mediated transcription.

Authors:  Takahiro Masaki; Ryosuke Suzuki; Mohsan Saeed; Ken-ichi Mori; Mami Matsuda; Hideki Aizaki; Koji Ishii; Noboru Maki; Tatsuo Miyamura; Yoshiharu Matsuura; Takaji Wakita; Tetsuro Suzuki
Journal:  J Virol       Date:  2010-03-17       Impact factor: 5.103

4.  Production of hepatitis C virus lacking the envelope-encoding genes for single-cycle infection by providing homologous envelope proteins or vesicular stomatitis virus glycoproteins in trans.

Authors:  Rui Li; Yan Qin; Ying He; Wanyin Tao; Nan Zhang; Cheguo Tsai; Paul Zhou; Jin Zhong
Journal:  J Virol       Date:  2010-12-15       Impact factor: 5.103

Review 5.  Ultrastructural and biochemical basis for hepatitis C virus morphogenesis.

Authors:  Viviana Falcón; Nelson Acosta-Rivero; Sirenia González; Santiago Dueñas-Carrera; Gillian Martinez-Donato; Ivon Menéndez; Rocio Garateix; José A Silva; Emilio Acosta; Juan Kourı
Journal:  Virus Genes       Date:  2017-02-23       Impact factor: 2.332

6.  Genetic complementation of hepatitis C virus nonstructural protein functions associated with replication exhibits requirements that differ from those for virion assembly.

Authors:  Morgan R Herod; Vera Schregel; Chris Hinds; Mengya Liu; John McLauchlan; Christopher J McCormick
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

7.  Morphogenesis of infectious hepatitis C virus particles.

Authors:  Tetsuro Suzuki
Journal:  Front Microbiol       Date:  2012-02-07       Impact factor: 5.640

Review 8.  Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design.

Authors:  Alexander W Tarr; Tanvi Khera; Kathrin Hueging; Julie Sheldon; Eike Steinmann; Thomas Pietschmann; Richard J P Brown
Journal:  Viruses       Date:  2015-07-17       Impact factor: 5.048

9.  NS2 is dispensable for efficient assembly of hepatitis C virus-like particles in a bipartite trans-encapsidation system.

Authors:  Matthew J Bentham; Najat Marraiki; Christopher J McCormick; David J Rowlands; Stephen Griffin
Journal:  J Gen Virol       Date:  2014-07-14       Impact factor: 3.891

Review 10.  The past, present and future of neutralizing antibodies for hepatitis C virus.

Authors:  Jonathan K Ball; Alexander W Tarr; Jane A McKeating
Journal:  Antiviral Res       Date:  2014-02-26       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.